AN ONGOING PHASE 2 STUDY OF IBRUTINIB COMBINED WITH VENETOCLAX IN PATIENTS WITH TREATMENT‐NAÏVE CLL/SLL. (June 2017) - Ghia, P.; Tam, C.S.; Siddiqi, T.; Stevens, D.; Flinn, I.W.; Russell, K.; Eckert, K.; Zhou, C.; Ninomoto, J.; James, D.F.; Wierda, W.G.